Skip to main content

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Clinical Trials

BRCC Research Institute 2026

< All Clinical Trials

Mevrometostat/Placebo + Enzalutamide in previously treated prostate cancer patients

Disease Type: Prostate

A Phase 3, Randomized, Double-blind, PlaceboControlled Study Of Mevrometostat (PF-06821497) With Enzalutamide In Metastatic Castration-sensitive Prostate Cancer (MEVPRO-3)

Locations

Alleghany , Blacksburg , Roanoke , Salem , Wytheville

View on ClinicalTrials.gov